You are here: Industry Insights > AIIMS

News List

8-10 months protection possible with COVID-19 vaccine: AIIMS director expresspharma
March 22, 2021
He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following COVID-appropriate behaviour.
Bharat Biotech’s Covaxin may provide Covid-19 immunity for 12 months pharmaceutical-technology
February 18, 2021
All India Institute of Medical Sciences (AIIMS) said that Bharat Biotech’s Covid-19 vaccine, Covaxin, may provide immunity against the disease for nine to 12 months, as per the mathematical calculations.
AIIMS find ivermectin prophylaxis reduces infection in Covid-19 patients pharmaceutical-technology
November 06, 2020
A study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha found that two doses of potential drug ivermectin prophylaxis resulted in a 73% reduction in Covid-19 infection.
AIIMS study finds ivermectin prophylaxis reduces infection in Covid-19 patients pharmaceutical-technology
November 06, 2020
A study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha has found that two doses of potential drug ivermectin prophylaxis resulted in a 73% reduction in Covid-19 infection.
‘Indiscriminate use of remdesivir, tocilizumab on Covid patients can cause more harm than good’ expresspharma
July 13, 2020
It said the pursuit of an effective treatment for COVID-19 has resulted in repurposing of several drugs which are not part of the main Clinical Management Protocol but have been indicated as investigational therapies.
Delhi HC orders AIIMS to resume dispensation of medicines from pharmacy without delay expresspharma
May 11, 2020
AIIMS told the court that its pharmacy has been made fully functional since May 6 and it operates from 10.00 am to 5.00 pm.